Lipella Pharmaceuticals I... (LIPO)
2.96
-0.11 (-3.58%)
At close: Jan 15, 2025, 3:58 PM
2.90
-2.01%
After-hours Jan 15, 2025, 05:15 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -4.62M | -2.60M | -1.87M | -61.66K | -61.85K |
| Depreciation & Amortization | 1.69K | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 1.36M | 747.40K | 728.80K | 57.71K | n/a |
| Other Working Capital | 237.23K | -327.93K | 175.25K | -7.48K | 24.68K |
| Other Non-Cash Items | 121.20K | 9.61K | -50.21K | 7.64K | 18.73K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -9.11K | 9.52K | 197.61K | -32.28K | 14.34K |
| Operating Cash Flow | -3.15M | -1.83M | -989.27K | -28.58K | -39.12K |
| Capital Expenditures | -14.43K | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | 300.55M | -300.55K | n/a | n/a |
| Sales Maturities Of Investments | n/a | 300.55K | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -300.55M | -300.55K | n/a | n/a |
| Investing Cash Flow | -14.43K | 300.55K | -300.55K | n/a | n/a |
| Debt Repayment | -275.00K | 275.00K | n/a | 57.04K | 25.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.61M | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 1.34M | 5.24M | 2.10M | 609.31K | 25.00K |
| Net Cash Flow | -1.83M | 3.71M | 807.09K | 580.73K | -14.12K |
| Free Cash Flow | -3.16M | -1.83M | -989.27K | -28.58K | -39.12K |